- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
2 Top Growth Stocks to Buy on the Dip
November 14, 2024
From Motley Fool
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
November 14, 2024
From Motley Fool
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
November 13, 2024
From Benzinga
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
November 13, 2024
From Motley Fool
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
November 13, 2024
From Benzinga
2 S&P 500 Dividend Stocks That Could Soar 30% or More, According to a Pair of Wall Street Analysts
November 13, 2024
From Motley Fool
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
November 12, 2024
From Benzinga
Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal
November 12, 2024
Tickers
LLY
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
From Benzinga
Tesla Remains Core For Gary Black Despite Price Cuts, Earnings Drop — Nvidia, Google, Eli Lilly Among Top Performers In Tech Bull's Portfolio
November 10, 2024
From Benzinga
1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock
November 10, 2024
Tickers
LLY
From Motley Fool
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
November 10, 2024
From Motley Fool
Is Viking Therapeutics a Buy on the Dip?
November 10, 2024
From Motley Fool
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
Investors Like Certainty. Trump's Win Gave Them Some.
November 08, 2024
From Motley Fool
Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.
November 08, 2024
Tickers
LLY
From Motley Fool
Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
November 07, 2024
From Benzinga
Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?
November 06, 2024
Tickers
LLY
From Motley Fool
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
November 06, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
From Benzinga
From Benzinga
From Benzinga
What's Going On With Hims & Hers Health Stock Monday?
November 04, 2024
From Benzinga
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
November 04, 2024
From Benzinga
Could This Near Trillion-Dollar Stock Be a Millionaire Maker?
November 03, 2024
From Motley Fool
Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
November 01, 2024
From Benzinga
From Benzinga
Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip
November 01, 2024
Tickers
LLY
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.